Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Katie B. Olney, PharmD, BCIDP
University of Kentucky HealthCare
Disclosure(s): No financial relationships to disclose
Poster(s):
(P-1257) Cefazolin Dosage Considerations for Methicillin-Susceptible
Staphylococcus aureus
(MSSA) Central Nervous System Infections: Exploring Optimal Regimens
Friday, October 18, 2024
12:15 PM – 1:30 PM
US PT
